Mkt Cap$2.24T-0.24%
24h Vol$62.47B
BTC Dom56.1%
ETH Dom9.6%
F&G22Extreme Fear
BTC$62,769.00-0.20% ETH$1,795.23+0.98% USDT$0.9988-0.02% BNB$570.12+0.34% USDC$0.9999+0.01% XRP$1.07-0.75% SOL$75.21-1.19% TRX$0.3248-0.76% FIGR_HELOC$1.03+1.91% HYPE$63.84-1.72% DOGE$0.0721-0.02% USDS$0.9999+0.02% RAIN$0.0142-1.58% LEO$9.55+0.30% ZEC$507.33-1.11% WBT$55.10+0.04% BTC$62,769.00-0.20% ETH$1,795.23+0.98% USDT$0.9988-0.02% BNB$570.12+0.34% USDC$0.9999+0.01% XRP$1.07-0.75% SOL$75.21-1.19% TRX$0.3248-0.76% FIGR_HELOC$1.03+1.91% HYPE$63.84-1.72% DOGE$0.0721-0.02% USDS$0.9999+0.02% RAIN$0.0142-1.58% LEO$9.55+0.30% ZEC$507.33-1.11% WBT$55.10+0.04%
News

obesity drugs

Total Stories
3
Section
obesity drugs
Why Are Novo Nordisk Shares Rising? GLP-1 Pill Launch Begins in U.S.
Market Analysis

Why Are Novo Nordisk Shares Rising in Premarket? GLP-1 Pill Launch Begins in U.S.

Novo Nordisk shares rose nearly 5% in premarket trading after the company launched its Wegovy weight-loss pill in the U.S.

Tim FriesJan 6, 20264 min read